Correlation Between Vertex Pharmaceuticals and Intellia Therapeutics
Can any of the company-specific risk be diversified away by investing in both Vertex Pharmaceuticals and Intellia Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vertex Pharmaceuticals and Intellia Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vertex Pharmaceuticals and Intellia Therapeutics, you can compare the effects of market volatilities on Vertex Pharmaceuticals and Intellia Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vertex Pharmaceuticals with a short position of Intellia Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vertex Pharmaceuticals and Intellia Therapeutics.
Diversification Opportunities for Vertex Pharmaceuticals and Intellia Therapeutics
0.21 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Vertex and Intellia is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Vertex Pharmaceuticals and Intellia Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intellia Therapeutics and Vertex Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vertex Pharmaceuticals are associated (or correlated) with Intellia Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intellia Therapeutics has no effect on the direction of Vertex Pharmaceuticals i.e., Vertex Pharmaceuticals and Intellia Therapeutics go up and down completely randomly.
Pair Corralation between Vertex Pharmaceuticals and Intellia Therapeutics
Given the investment horizon of 90 days Vertex Pharmaceuticals is expected to generate 0.39 times more return on investment than Intellia Therapeutics. However, Vertex Pharmaceuticals is 2.57 times less risky than Intellia Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Intellia Therapeutics is currently generating about -0.03 per unit of risk. If you would invest 28,323 in Vertex Pharmaceuticals on August 31, 2024 and sell it today you would earn a total of 18,490 from holding Vertex Pharmaceuticals or generate 65.28% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vertex Pharmaceuticals vs. Intellia Therapeutics
Performance |
| Timeline |
| Vertex Pharmaceuticals |
| Intellia Therapeutics |
Vertex Pharmaceuticals and Intellia Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vertex Pharmaceuticals and Intellia Therapeutics
The main advantage of trading using opposite Vertex Pharmaceuticals and Intellia Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vertex Pharmaceuticals position performs unexpectedly, Intellia Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intellia Therapeutics will offset losses from the drop in Intellia Therapeutics' long position.| Vertex Pharmaceuticals vs. Biomarin Pharmaceutical | Vertex Pharmaceuticals vs. Sarepta Therapeutics | Vertex Pharmaceuticals vs. Alnylam Pharmaceuticals | Vertex Pharmaceuticals vs. Intellia Therapeutics |
| Intellia Therapeutics vs. Editas Medicine | Intellia Therapeutics vs. Caribou Biosciences | Intellia Therapeutics vs. Crispr Therapeutics AG | Intellia Therapeutics vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |